Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Lin, JT; Lachmann, E; Nagler, W
   Paraneoplastic cerebellar degeneration as the first manifestation of cancer
   JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
   
   J.T. Lin et al., "Paraneoplastic cerebellar degeneration as the first manifestation of cancer", J WOMEN H G, 10(5), 2001, pp. 495-502
2. Kim, SJ; Uehara, H; Karashima, T; Mccarty, M; Shih, N; Fidler, IJ
   Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice
   NEOPLASIA
   
   S.J. Kim et al., "Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice", NEOPLASIA, 3(1), 2001, pp. 33-42
3. Smith, SK
   Angiogenesis and reproduction
   BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
   
   S.K. Smith, "Angiogenesis and reproduction", BR J OBST G, 108(8), 2001, pp. 777-783
4. Schneider, J; Gonzalez-Roces, S; Pollan, M; Lucas, R; Tejerina, A; Martin, M; Alba, A
   Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy
   BREAST CANCER RESEARCH
   
   J. Schneider et al., "Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy", BREAST CA R, 3(3), 2001, pp. 183-191
5. Kriangkum, J; Xu, BW; Nagata, LP; Fulton, RE; Suresh, MR
   Bispecific and bifunctional single chain recombinant antibodies
   BIOMOLECULAR ENGINEERING
   
   J. Kriangkum et al., "Bispecific and bifunctional single chain recombinant antibodies", BIOMOL ENG, 18(2), 2001, pp. 31-40
6. Zufia, L; Aldaz, A; Castellanos, C; Giraldez, J
   Simple and rapid determination of carboplatin in plasma by highperformanceliquid chromatography. Error pattern and application to clinical pharmacokinetic studies
   JOURNAL OF CHROMATOGRAPHY B
   
   L. Zufia et al., "Simple and rapid determination of carboplatin in plasma by highperformanceliquid chromatography. Error pattern and application to clinical pharmacokinetic studies", J CHROMAT B, 764(1-2), 2001, pp. 457-464
7. Kartalou, M; Essigmann, JM
   Mechanisms of resistance to cisplatin
   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
   
   M. Kartalou e J.M. Essigmann, "Mechanisms of resistance to cisplatin", MUT RES-F M, 478(1-2), 2001, pp. 23-43
8. Harries, M; Kaye, SB
   Recent advances in the treatment of epithelial ovarian cancer
   EXPERT OPINION ON INVESTIGATIONAL DRUGS
   
   M. Harries e S.B. Kaye, "Recent advances in the treatment of epithelial ovarian cancer", EXPERT OP I, 10(9), 2001, pp. 1715-1724
9. Tenev, T; Marani, M; McNeish, I; Lemoine, NR
   Pro-caspase-3 overexpression sensitises ovarian cancer cells to proteasomeinhibitors
   CELL DEATH AND DIFFERENTIATION
   
   T. Tenev et al., "Pro-caspase-3 overexpression sensitises ovarian cancer cells to proteasomeinhibitors", CELL DEAT D, 8(3), 2001, pp. 256-264
10. Matsumoto, Y; Ishiko, O; Deguchi, M; Nakagawa, E; Ogita, S
    Cyclooxygenase-2 expression in normal ovaries and epithelial ovarian neoplasms
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    Y. Matsumoto et al., "Cyclooxygenase-2 expression in normal ovaries and epithelial ovarian neoplasms", INT J MOL M, 8(1), 2001, pp. 31-36
11. Hartmann, F; Renner, C; Jung, W; da Costa, L; Tembrink, S; Held, G; Sek, A; Konig, J; Bauer, S; Kloft, M; Pfreundschuh, M
    Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: Role of infusion schedule and costimulation with cytokines
    CLINICAL CANCER RESEARCH
    
    F. Hartmann et al., "Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: Role of infusion schedule and costimulation with cytokines", CLIN CANC R, 7(7), 2001, pp. 1873-1881
12. Takahashi, A; Kono, K; Amemiya, H; Iizuka, H; Fujii, H; Matsumoto, Y
    Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer
    CLINICAL CANCER RESEARCH
    
    A. Takahashi et al., "Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer", CLIN CANC R, 7(1), 2001, pp. 74-80
13. Kurz, C; Tempfer, CB; Boecskoer, S; Unfried, G; Nagele, F; Hefler, LA
    The PROGINS progesterone receptor gene polymorphism and idiopathic recurrent miscarriage
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION
    
    C. Kurz et al., "The PROGINS progesterone receptor gene polymorphism and idiopathic recurrent miscarriage", J SOC GYN I, 8(5), 2001, pp. 295-298
14. Afify, AM; Ferguson, AW; Davila, RM; Werness, BA
    Expression of CD44S and CD44v5 is more common in stage III than in stage Iserous ovarian carcinomas
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    
    A.M. Afify et al., "Expression of CD44S and CD44v5 is more common in stage III than in stage Iserous ovarian carcinomas", APPL IMMUNO, 9(4), 2001, pp. 309-314
15. Fowers, KD; Callahan, J; Byron, P; Kopecek, JI
    Preparation of Fab' from murine IgG2a for thiol reactive conjugation
    JOURNAL OF DRUG TARGETING
    
    K.D. Fowers et al., "Preparation of Fab' from murine IgG2a for thiol reactive conjugation", J DRUG TAR, 9(4), 2001, pp. 281-294
16. Geisler, JP; Geisler, HE
    Tumor markers and molecular biological markers in gynecologic malignancies
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
    
    J.P. Geisler e H.E. Geisler, "Tumor markers and molecular biological markers in gynecologic malignancies", CUR OP OBST, 13(1), 2001, pp. 31-39
17. Giavazzi, R; Taraboletti, G
    Preclinical development of metalloproteasis inhibitors in cancer therapy
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    
    R. Giavazzi e G. Taraboletti, "Preclinical development of metalloproteasis inhibitors in cancer therapy", CR R ONC H, 37(1), 2001, pp. 53-60
18. Zoli, W; Ricotti, L; Tesei, A; Barzanti, F; Amadori, D
    In vitro preclinical models for a rational design of chemotherapy combinations in human tumors
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    
    W. Zoli et al., "In vitro preclinical models for a rational design of chemotherapy combinations in human tumors", CR R ONC H, 37(1), 2001, pp. 69-82
19. Minko, T; Kopeckova, P; Kopecek, J
    Mechanisms of anticancer action of HPMA copolymer-bound doxorubicin
    MACROMOLECULAR SYMPOSIA
    
    T. Minko et al., "Mechanisms of anticancer action of HPMA copolymer-bound doxorubicin", MACRO SYMP, 172, 2001, pp. 35-47
20. Shimizu, Y; Utsugi, K; Umezawa, S; Shimizu, K; Hasumi, K; Suzuki, M; Takaku, F
    Effect of human urinary macrophage colony-stimulating factor on the immunefunctions and the blood cell counts in patients with ovarian carcinoma receiving cytotoxic chemotherapy
    ONCOLOGY REPORTS
    
    Y. Shimizu et al., "Effect of human urinary macrophage colony-stimulating factor on the immunefunctions and the blood cell counts in patients with ovarian carcinoma receiving cytotoxic chemotherapy", ONCOL REP, 8(4), 2001, pp. 767-772
21. Fujioka, T; Takebayashi, Y; Kihana, T; Kusanagi, Y; Hamada, K; Ochi, H; Uchida, T; Fukumoto, M; Ito, M
    Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma
    ONCOLOGY REPORTS
    
    T. Fujioka et al., "Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma", ONCOL REP, 8(2), 2001, pp. 249-255
22. Skirnisdottir, I; Sorbe, B; Karlsson, M; Seidal, T
    Prognostic importance of DNA ploidy and p53 in early stages of epithelial ovarian carcinoma
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    I. Skirnisdottir et al., "Prognostic importance of DNA ploidy and p53 in early stages of epithelial ovarian carcinoma", INT J ONCOL, 19(6), 2001, pp. 1295-1302
23. Yoshida, H; Ishiko, O; Sumi, T; Matsumoto, Y; Ogita, S
    Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    H. Yoshida et al., "Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas", INT J ONCOL, 19(3), 2001, pp. 537-542
24. Sarantaus, L; Auranen, A; Nevanlinna, H
    BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    L. Sarantaus et al., "BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families", INT J ONCOL, 18(4), 2001, pp. 831-835
25. Sarantaus, L; Vahteristo, P; Bloom, E; Tamminen, A; Unkila-Kallio, L; Butzow, R; Nevanlinna, H
    BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients
    EUROPEAN JOURNAL OF HUMAN GENETICS
    
    L. Sarantaus et al., "BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients", EUR J HUM G, 9(6), 2001, pp. 424-430
26. Chen, FD; Hsieh, BT; Wang, HE; Ou, YH; Yang, WK; Whang-Peng, J; Liu, RS; Knapp, FF; Ting, G; Yen, SH
    Efficacy of Re-188-labelled sulphur colloid on prolongation of survival time in melanoma-bearing animals
    NUCLEAR MEDICINE AND BIOLOGY
    
    F.D. Chen et al., "Efficacy of Re-188-labelled sulphur colloid on prolongation of survival time in melanoma-bearing animals", NUCL MED BI, 28(7), 2001, pp. 835-844
27. Downer, JD; Jones, LA; Engelbach, JA; Lich, LL; Mao, W; Carlson, KE; Katzenellenbogen, JA; Welch, MJ
    Comparison of animal models for the evaluation of radiolabeled androgens
    NUCLEAR MEDICINE AND BIOLOGY
    
    J.D. Downer et al., "Comparison of animal models for the evaluation of radiolabeled androgens", NUCL MED BI, 28(6), 2001, pp. 613-626
28. Pizzato, M; Blair, ED; Fling, M; Kopf, J; Tomassetti, A; Weiss, RA; Takeuchi, Y
    Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells
    GENE THERAPY
    
    M. Pizzato et al., "Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells", GENE THER, 8(14), 2001, pp. 1088-1096
29. Varda-Bloom, N; Shaish, A; Gonen, A; Levanon, K; Greenbereger, S; Ferber, S; Levkovitz, H; Castel, D; Goldberg, I; Afek, A; Kopolovitc, Y; Harats, D
    Tissue-specific gene therapy directed to tumor angiogenesis
    GENE THERAPY
    
    N. Varda-Bloom et al., "Tissue-specific gene therapy directed to tumor angiogenesis", GENE THER, 8(11), 2001, pp. 819-827
30. Guven, K; Kittler, H; Wolff, K; Pehamberger, H
    Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients
    MELANOMA RESEARCH
    
    K. Guven et al., "Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients", MELANOMA RE, 11(4), 2001, pp. 411-415
31. Cemazar, M; Miklavcic, D; Mir, LM; Belchradek, J; Bonnay, M; Fourcault, D; Sersa, G
    Electrochemotherapy of tumours resistant to cisplatin: a study in a murinetumour model
    EUROPEAN JOURNAL OF CANCER
    
    M. Cemazar et al., "Electrochemotherapy of tumours resistant to cisplatin: a study in a murinetumour model", EUR J CANC, 37(9), 2001, pp. 1166-1172
32. Davidson, B; Reich, R; Berner, A; Givant-Horwitz, V; Goldberg, I; Risberg, B; Kristensen, GB; Trope, CG; Bryne, M; Kopolovic, J; Nesland, JM
    Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels
    EUROPEAN JOURNAL OF CANCER
    
    B. Davidson et al., "Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels", EUR J CANC, 37(16), 2001, pp. 2040-2049
33. Shiah, JG; Dvorak, M; Kopeckova, P; Sun, Y; Peterson, CM; Kopecek, J
    Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice
    EUROPEAN JOURNAL OF CANCER
    
    J.G. Shiah et al., "Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice", EUR J CANC, 37(1), 2001, pp. 131-139
34. Oberhoff, C; Hoffmann, O; Winkler, UH; Schindler, AE
    Hemostatic effects of high-dose megestrol acetate therapy in patients withadvanced gynecological cancer
    GYNECOLOGICAL ENDOCRINOLOGY
    
    C. Oberhoff et al., "Hemostatic effects of high-dose megestrol acetate therapy in patients withadvanced gynecological cancer", GYNECOL END, 15(5), 2001, pp. 341-348
35. Acquati, F; Morelli, C; Cinquetti, R; Bianchi, MG; Porrini, D; Varesco, L; Gismondi, V; Rocchetti, R; Talevi, S; Possati, L; Magnanini, C; Tibiletti, MG; Bernasconi, B; Daidone, MG; Shridhar, V; Smith, DI; Negrini, M; Barbanti-Brodano, G; Taramelli, R
    Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27
    ONCOGENE
    
    F. Acquati et al., "Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27", ONCOGENE, 20(8), 2001, pp. 980-988
36. Zhang, DM; Vuocolo, S; Masciullo, V; Sava, T; Giordano, A; Soprano, DR; Soprano, KJ
    Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression
    ONCOGENE
    
    D.M. Zhang et al., "Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression", ONCOGENE, 20(55), 2001, pp. 7935-7944
37. Vikhanskaya, F; Bani, MR; Borsotti, P; Ghilardi, C; Ceruti, R; Ghisleni, G; Marabese, M; Giavazzi, R; Broggini, M; Taraboletti, G
    p73 overexpression increases VEGF and reduces thrombospondin-1 production:implications for tumor angiogenesis
    ONCOGENE
    
    F. Vikhanskaya et al., "p73 overexpression increases VEGF and reduces thrombospondin-1 production:implications for tumor angiogenesis", ONCOGENE, 20(50), 2001, pp. 7293-7300
38. Ruangpanit, N; Chan, D; Holmbeck, K; Birkedal-Hansen, H; Polarek, J; Yang, CL; Bateman, JF; Thompson, EW
    Gelatinase A (MMP-2) activation by skin fibroblasts: dependence on MT1-MMPexpression and fibrillar collagen form
    MATRIX BIOLOGY
    
    N. Ruangpanit et al., "Gelatinase A (MMP-2) activation by skin fibroblasts: dependence on MT1-MMPexpression and fibrillar collagen form", MATRIX BIOL, 20(3), 2001, pp. 193-203
39. Vizcaino, I; Torregrosa, A; Higueras, V; Morote, V; Cremades, A; Torres, V; Olmos, S; Molins, C
    Metastasis to the breast from extramammary malignancies: a report of four cases and a review of literature
    EUROPEAN RADIOLOGY
    
    I. Vizcaino et al., "Metastasis to the breast from extramammary malignancies: a report of four cases and a review of literature", EUR RADIOL, 11(9), 2001, pp. 1659-1665
40. Chung, P; Allerton, R
    Malignant meningitis secondary to ovarian carcinoma: An unusual occurrence
    CLINICAL ONCOLOGY
    
    P. Chung e R. Allerton, "Malignant meningitis secondary to ovarian carcinoma: An unusual occurrence", CL ONCOL-UK, 13(2), 2001, pp. 112-113
41. Perego, P; Corna, E; De Cesare, M; Gatti, L; Polizzi, D; Pratesi, G; Supino, R; Zunino, F
    Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines
    CURRENT MEDICINAL CHEMISTRY
    
    P. Perego et al., "Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines", CURR MED CH, 8(1), 2001, pp. 31-37
42. Mastrobattista, E; Kapel, RHG; Eggenhuisen, MH; Roholl, PJM; Crommelin, DJA; Hennink, WE; Storm, G
    Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells
    CANCER GENE THERAPY
    
    E. Mastrobattista et al., "Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells", CANC GENE T, 8(6), 2001, pp. 405-413
43. Weinrib, L; Li, JH; Donovan, J; Huang, D; Liu, FF
    Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma
    CANCER GENE THERAPY
    
    L. Weinrib et al., "Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma", CANC GENE T, 8(5), 2001, pp. 352-360
44. Shmueli, E; Leider-Trejo, L; Schwartz, I; Aderka, D; Inbar, M
    Primary papillary serous carcinoma of the peritoneum in a man
    ANNALS OF ONCOLOGY
    
    E. Shmueli et al., "Primary papillary serous carcinoma of the peritoneum in a man", ANN ONCOL, 12(4), 2001, pp. 563-567
45. Kimmig, R; Wimberger, P; Kapsner, T; Hillemanns, P
    Flow cytometric DNA analysis using cytokeratin labeling for identificationof tumor cells in carcinomas of the breast and the female genital tract
    ANALYTICAL CELLULAR PATHOLOGY
    
    R. Kimmig et al., "Flow cytometric DNA analysis using cytokeratin labeling for identificationof tumor cells in carcinomas of the breast and the female genital tract", ANAL CELL P, 22(3), 2001, pp. 165-178
46. Ohta, M; Konno, H; Tanaka, T; Baba, M; Kamiya, K; Oba, K; Kaneko, T; Syouji, T; Igarashi, A; Nakamura, S
    Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    M. Ohta et al., "Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer", JPN J CANC, 92(6), 2001, pp. 688-695
47. Higashi, T; Sasagawa, T; Inoue, M; Oka, R; Leng, SY; Saijoh, K
    Overexpression of latent transforming growth factor-beta 1 (TGF-beta 1) binding protein 1 (LTBP-1) in association with TGF-beta 1 in ovarian carcinoma
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    T. Higashi et al., "Overexpression of latent transforming growth factor-beta 1 (TGF-beta 1) binding protein 1 (LTBP-1) in association with TGF-beta 1 in ovarian carcinoma", JPN J CANC, 92(5), 2001, pp. 506-515
48. Gerschenson, M; Paik, CY; Gaukler, EL; Diwan, BA; Poirier, MC
    Cisplatin exposure induces mitochondrial toxicity in pregnant rats and their fetuses
    REPRODUCTIVE TOXICOLOGY
    
    M. Gerschenson et al., "Cisplatin exposure induces mitochondrial toxicity in pregnant rats and their fetuses", REPROD TOX, 15(5), 2001, pp. 525-531
49. Luisi, S; Florio, P; Reis, FM; Petraglia, F
    Expression and secretion of activin A: possible physiological and clinicalimplications
    EUROPEAN JOURNAL OF ENDOCRINOLOGY
    
    S. Luisi et al., "Expression and secretion of activin A: possible physiological and clinicalimplications", EUR J ENDOC, 145(3), 2001, pp. 225-236
50. Edmonson, JH; Suman, VJ; Dalton, RJ; Bro, WC; Gallenberg, MM; Long, HJ; Levitt, R; Hatfield, AK; Krook, JE; Mailliard, JA; Gerstner, JB
    Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: Anorth central cancer treatment group study
    CANCER INVESTIGATION
    
    J.H. Edmonson et al., "Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: Anorth central cancer treatment group study", CANCER INV, 19(6), 2001, pp. 597-602
51. Mangiarotti, F; Miotti, S; Galmozzi, E; Mazzi, M; Sforzini, S; Canevari, S; Tomassetti, A
    Functional effect of point mutations in the alpha-folate receptor gene of CABA I ovarian carcinoma cells
    JOURNAL OF CELLULAR BIOCHEMISTRY
    
    F. Mangiarotti et al., "Functional effect of point mutations in the alpha-folate receptor gene of CABA I ovarian carcinoma cells", J CELL BIOC, 81(3), 2001, pp. 488-498
52. Pejovic, T; Koul, A; Olsen, D; Chambers, JT
    NoBRCA1 germline mutation in a family with uterine papillary serous carcinoma: A case report
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    
    T. Pejovic et al., "NoBRCA1 germline mutation in a family with uterine papillary serous carcinoma: A case report", EUR J GYN O, 22(5), 2001, pp. 336-338
53. Umesaki, N; Tanaka, T; Miyama, M; Ogita, S; Ochi, H
    Usefulness of positron emission tomography for diagnosis of malignancy in a calcified lesion: A case report
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    
    N. Umesaki et al., "Usefulness of positron emission tomography for diagnosis of malignancy in a calcified lesion: A case report", EUR J GYN O, 22(4), 2001, pp. 263-265
54. Halperin, R; Zehavi, S; Dar, P; Habler, L; Hadas, E; Bukovsky, I; Schneider, D
    Clinical and molecular comparison between borderline serous ovarian tumorsand advanced serous papillary ovarian carcinomas
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    
    R. Halperin et al., "Clinical and molecular comparison between borderline serous ovarian tumorsand advanced serous papillary ovarian carcinomas", EUR J GYN O, 22(4), 2001, pp. 292-296
55. Yuce, K; Baykal, C; Genc, C; Al, A; Ayhan, A
    Diagnostic and prognostic value of serum and peritoneal fluid lactate dehydrogenase in epithelial ovarian cancer
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    
    K. Yuce et al., "Diagnostic and prognostic value of serum and peritoneal fluid lactate dehydrogenase in epithelial ovarian cancer", EUR J GYN O, 22(3), 2001, pp. 228-232
56. Haughney, RVM; Slade, RJ; Brain, AN
    An isolated abdominal wall metastasis of ovarian carcinoma ten years afterprimary surgery
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    
    R.V.M. Haughney et al., "An isolated abdominal wall metastasis of ovarian carcinoma ten years afterprimary surgery", EUR J GYN O, 22(2), 2001, pp. 102-103
57. Wang, PH; Yuan, CC; Juang, CM; Lai, CR; Yen, MS; Chao, HT; Ng, HT
    Primary epithelial ovarian carcinoma in Taiwanese women
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    
    P.H. Wang et al., "Primary epithelial ovarian carcinoma in Taiwanese women", EUR J GYN O, 22(1), 2001, pp. 57-60
58. Wakahara, F; Kikkawa, F; Nawa, A; Tamakoshi, K; Ino, K; Maeda, O; Kawai, M; Mizutani, S
    Diagnostic efficacy of tumor markers, sonography, and intraoperative frozen section for ovarian tumors
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    
    F. Wakahara et al., "Diagnostic efficacy of tumor markers, sonography, and intraoperative frozen section for ovarian tumors", GYNECOL OBS, 52(3), 2001, pp. 147-152
59. Cormio, G; di Vagno, G; Melilli, GA; Loverro, G; Cramarossa, D; Selvaggi, L
    Ovarian carcinoma metastatic to the breast
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    
    G. Cormio et al., "Ovarian carcinoma metastatic to the breast", GYNECOL OBS, 52(1), 2001, pp. 73-74
60. Matsushita, H; Kurabayashi, T; Tomita, M; Yamamoto, Y; Aoki, Y; Tanaka, K
    Disseminated intravascular coagulation associated with intratumoral hemorrhage of ovarian cancer
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    
    H. Matsushita et al., "Disseminated intravascular coagulation associated with intratumoral hemorrhage of ovarian cancer", GYNECOL OBS, 51(4), 2001, pp. 274-276
61. Kikuchi, T; Sugawara, Y; Kajihara, M; Nakata, S; Mochizuki, T; Ikezoe, J; Katayama, T
    Accumulation of Tc-99m HMDP in ovarian serous papillary adenocarcinoma reflecting ongoing calcification
    CLINICAL NUCLEAR MEDICINE
    
    T. Kikuchi et al., "Accumulation of Tc-99m HMDP in ovarian serous papillary adenocarcinoma reflecting ongoing calcification", CLIN NUCL M, 26(10), 2001, pp. 886-887
62. Tinger, A; Waldron, T; Peluso, N; Katin, NJ; Dosoretz, DE; Blitzer, PH; Rubenstein, JH; Garton, GR; Nakfoor, BA; Patrice, SJ; Chuang, L; Orr, JW
    Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    A. Tinger et al., "Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma", INT J RAD O, 51(5), 2001, pp. 1256-1263
63. Morgan, RJ; Synold, T; Carr, BI; Doroshow, JH; Womack, EP; Shibata, S; Somlo, G; Raschko, J; Leong, L; McNamara, M; Chow, W; Tetef, M; Margolin, K; Akman, S; Longmate, J
    Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    R.J. Morgan et al., "Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy", CANC CHEMOT, 47(4), 2001, pp. 327-332
64. Nakayama, K; Kanzaki, A; Takebayashi, Y; Toi, M; Bando, H; Nabei, T; Miyazaki, K; Fukumoto, M
    Different features of angiogenesis between ovarian and breast carcinoma
    CANCER LETTERS
    
    K. Nakayama et al., "Different features of angiogenesis between ovarian and breast carcinoma", CANCER LETT, 170(2), 2001, pp. 161-167
65. Wurl, P; Fittkau, M; Meye, A; Bartel, F; Schmidt, H; Schonfelder, M; Taubert, H
    Low detection rate of p53 antibodies in sera of soft tissue sarcoma patients
    CANCER LETTERS
    
    P. Wurl et al., "Low detection rate of p53 antibodies in sera of soft tissue sarcoma patients", CANCER LETT, 170(2), 2001, pp. 199-205
66. Alves, F; Borchers, U; Padge, B; Augustin, H; Nebendahl, K; Kloppel, G; Tietze, LF
    Inhibitory effect of a matrix metalloproteinase inhibitor on growth and spread of human pancreatic ductal adenocarcinoma evaluated in an orthotopic severe combined immunodeficient (SCID) mouse model
    CANCER LETTERS
    
    F. Alves et al., "Inhibitory effect of a matrix metalloproteinase inhibitor on growth and spread of human pancreatic ductal adenocarcinoma evaluated in an orthotopic severe combined immunodeficient (SCID) mouse model", CANCER LETT, 165(2), 2001, pp. 161-170
67. Son, KK; Rosenblatt, J
    Overexpression of protein kinase A-RI alpha reduces lipofection efficiencyof cisplatin-resistant human tumor cells
    CANCER LETTERS
    
    K.K. Son e J. Rosenblatt, "Overexpression of protein kinase A-RI alpha reduces lipofection efficiencyof cisplatin-resistant human tumor cells", CANCER LETT, 165(1), 2001, pp. 81-86
68. Goldberg, H; Stein, ME; Steiner, M; Sprecher, E; Beck, D; Kuten, A
    Consolidation radiation therapy following cytoreductive surgery, chemotherapy and second-look laparotomy for epithelial ovarian carcinoma: Long-term follow-up
    TUMORI
    
    H. Goldberg et al., "Consolidation radiation therapy following cytoreductive surgery, chemotherapy and second-look laparotomy for epithelial ovarian carcinoma: Long-term follow-up", TUMORI, 87(4), 2001, pp. 248-251
69. Ikeda, K; Miura, K; Himeno, S; Imura, N; Naganuma, A
    Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum
    MOLECULAR AND CELLULAR BIOCHEMISTRY
    
    K. Ikeda et al., "Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum", MOL C BIOCH, 219(1-2), 2001, pp. 51-56
70. Karlsson, G; Nygren, P; Glimelius, B
    Economic aspects of chemotherapy
    ACTA ONCOLOGICA
    
    G. Karlsson et al., "Economic aspects of chemotherapy", ACTA ONCOL, 40(2-3), 2001, pp. 412-433
71. Hamana, S; Motoyama, S; Takeuchi, S; Ku, Y; Yoshida, S; Miyahara, Y; Tateiwa, Y; Maruo, T
    Super high-dose intraarterial cisplatin infusion under percutaneous pelvicperfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma - I. Analysis for pharmacokinetics, tumor response, and toxicity of platinum
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    
    S. Hamana et al., "Super high-dose intraarterial cisplatin infusion under percutaneous pelvicperfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma - I. Analysis for pharmacokinetics, tumor response, and toxicity of platinum", AM J CL ONC, 24(3), 2001, pp. 241-246
72. Giblin, J; Fanucchi, MP; McGuire, WP
    Clear cell carcinoma of the ovary - A remarkable case
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    
    J. Giblin et al., "Clear cell carcinoma of the ovary - A remarkable case", AM J CL ONC, 24(1), 2001, pp. 99-100
73. Che, MX; Tornos, C; Deavers, MT; Malpica, A; Gershenson, DM; Silva, EG
    Ovarian mixed-epithelial carcinomas with a microcystic pattern and signet-ring cells
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    
    M.X. Che et al., "Ovarian mixed-epithelial carcinomas with a microcystic pattern and signet-ring cells", INT J GYN P, 20(4), 2001, pp. 323-328
74. Baergen, RN; Warren, CD; Isacson, C; Ellenson, LH
    Early uterine serous carcinoma: Clonal origin of extrauterine disease
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    
    R.N. Baergen et al., "Early uterine serous carcinoma: Clonal origin of extrauterine disease", INT J GYN P, 20(3), 2001, pp. 214-219
75. Smith, NL; Halliday, BE; Finley, JL; Wennerberg, AEK
    Immunohistochemical distribution of tumor-associated antigen CA6 in gynecological neoplasms as detected by monoclonal antibody DS6
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    
    N.L. Smith et al., "Immunohistochemical distribution of tumor-associated antigen CA6 in gynecological neoplasms as detected by monoclonal antibody DS6", INT J GYN P, 20(3), 2001, pp. 260-266
76. Davidson, B; Goldberg, I; Kopolovic, J; Gotlieb, WH; Givant-Horwitz, V; Nesland, JM; Berner, A; Ben-Baruch, G; Bryne, M; Reich, R
    Expression of angiogenesis-related genes in ovarian carcinoma - A clinicopathologic study
    CLINICAL & EXPERIMENTAL METASTASIS
    
    B. Davidson et al., "Expression of angiogenesis-related genes in ovarian carcinoma - A clinicopathologic study", CLIN EXP M, 18(6), 2001, pp. 501-507
77. Koshiyama, M; Fujii, H; Kinezaki, M; Morita, Y; Nanno, H; Yoshida, M
    Immunohistochemical expression of topoisomerase II alpha (Topo II alpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas
    ANTICANCER RESEARCH
    
    M. Koshiyama et al., "Immunohistochemical expression of topoisomerase II alpha (Topo II alpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas", ANTICANC R, 21(4B), 2001, pp. 2925-2932
78. Koshiyama, M; Fujii, H; Kinezaki, M; Yoshida, M
    Correlation between Topo II alpha expression and chemosensitivity testing for Topo II-targeting drugs in gynaecological carcinomas
    ANTICANCER RESEARCH
    
    M. Koshiyama et al., "Correlation between Topo II alpha expression and chemosensitivity testing for Topo II-targeting drugs in gynaecological carcinomas", ANTICANC R, 21(2A), 2001, pp. 905-910
79. Pohl, G; Suchomel, RW; Stranzl, T; Depisch, D; Stiglbauer, W; Filipits, M; Pirker, R
    Expression of the lung resistance protein in primary colorectal carcinomas
    ANTICANCER RESEARCH
    
    G. Pohl et al., "Expression of the lung resistance protein in primary colorectal carcinomas", ANTICANC R, 21(1A), 2001, pp. 201-204
80. Kopecek, J; Kopeckova, P; Minko, T; Lu, ZR; Peterson, CM
    Water soluble polymers in tumor targeted delivery
    JOURNAL OF CONTROLLED RELEASE
    
    J. Kopecek et al., "Water soluble polymers in tumor targeted delivery", J CONTR REL, 74(1-3), 2001, pp. 147-158
81. Kasuya, Y; Lu, ZR; Kopeckova, P; Minko, T; Tabibi, SE; Kopecek, J
    Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates
    JOURNAL OF CONTROLLED RELEASE
    
    Y. Kasuya et al., "Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates", J CONTR REL, 74(1-3), 2001, pp. 203-211
82. Minko, T; Kopeckova, P; Kopecek, J
    Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells
    JOURNAL OF CONTROLLED RELEASE
    
    T. Minko et al., "Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells", J CONTR REL, 71(3), 2001, pp. 227-237
83. Konecny, G; Untch, M; Slamon, D; Beryt, M; Kahlert, S; Felber, M; Langer, E; Lude, S; Hepp, H; Pegram, M
    Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples
    BREAST CANCER RESEARCH AND TREATMENT
    
    G. Konecny et al., "Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples", BREAST CANC, 67(3), 2001, pp. 223-233
84. Sowery, RD; Jensen, C; Morrison, KB; Horsman, DE; Sorensen, PHB; Webber, EM
    Comparative genomic hybridization detects multiple chromosomal amplifications and deletions in undifferentiated embryonal sarcoma of the liver
    CANCER GENETICS AND CYTOGENETICS
    
    R.D. Sowery et al., "Comparative genomic hybridization detects multiple chromosomal amplifications and deletions in undifferentiated embryonal sarcoma of the liver", CANC GENET, 126(2), 2001, pp. 128-133
85. Gross, E; Kiechle, M; Arnold, N
    Mutation analysis of p53 in ovarian rumors by DHPLC
    JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
    
    E. Gross et al., "Mutation analysis of p53 in ovarian rumors by DHPLC", J BIOCH BIO, 47(1-2), 2001, pp. 73-81
86. Perico, ME; Chinol, M; Nacca, A; Luison, E; Paganelli, G; Canevari, S
    The humoral immune response to macrocyclic chelating agent DOTA depends onthe carrier molecule
    JOURNAL OF NUCLEAR MEDICINE
    
    M.E. Perico et al., "The humoral immune response to macrocyclic chelating agent DOTA depends onthe carrier molecule", J NUCL MED, 42(11), 2001, pp. 1697-1703
87. Colgan, TJ; Murphy, J; Cole, DEC; Narod, S; Rosen, B
    Occult carcinoma in prophylactic oophorectomy specimens - Prevalence and association with BRCA germline mutation status
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    
    T.J. Colgan et al., "Occult carcinoma in prophylactic oophorectomy specimens - Prevalence and association with BRCA germline mutation status", AM J SURG P, 25(10), 2001, pp. 1283-1289
88. Seiden, MV; Spitzer, TR; McAfee, S; Fuller, AF
    Successful pregnancy after high-dose cyclophosphamide, carboplatinum, and taxol with peripheral blood stem cell transplant in a young woman with ovarian carcinoma
    GYNECOLOGIC ONCOLOGY
    
    M.V. Seiden et al., "Successful pregnancy after high-dose cyclophosphamide, carboplatinum, and taxol with peripheral blood stem cell transplant in a young woman with ovarian carcinoma", GYNECOL ONC, 83(2), 2001, pp. 412-414
89. Cormio, G; Cormio, MD; Di Gesu, G; Loverro, G; Selvaggi, L
    Calyceal rupture and perirenal urinoma as a presenting sign of recurrent ovarian cancer
    GYNECOLOGIC ONCOLOGY
    
    G. Cormio et al., "Calyceal rupture and perirenal urinoma as a presenting sign of recurrent ovarian cancer", GYNECOL ONC, 83(2), 2001, pp. 415-417
90. Erzen, M; Rakar, S; Klancar, B; Syrjanen, K
    Endometriosis-associated ovarian carcinoma (EAOC): An entity distinct fromother ovarian carcinomas as suggested by a nested case-control study
    GYNECOLOGIC ONCOLOGY
    
    M. Erzen et al., "Endometriosis-associated ovarian carcinoma (EAOC): An entity distinct fromother ovarian carcinomas as suggested by a nested case-control study", GYNECOL ONC, 83(1), 2001, pp. 100-108
91. Kheterpal, P; Singh, M; Mondul, A; Dharmarajan, L; Soni, A
    Malignant pericardial effusion and cardiac tamponade in endometrial adenocarcinoma
    GYNECOLOGIC ONCOLOGY
    
    P. Kheterpal et al., "Malignant pericardial effusion and cardiac tamponade in endometrial adenocarcinoma", GYNECOL ONC, 83(1), 2001, pp. 143-145
92. Van Trappen, PO; Pepper, MS
    Lymphangiogenesis and lymph node microdissemination
    GYNECOLOGIC ONCOLOGY
    
    P.O. Van Trappen e M.S. Pepper, "Lymphangiogenesis and lymph node microdissemination", GYNECOL ONC, 82(1), 2001, pp. 1-3
93. Rieder, J; Jahnke, R; Schloesser, M; Seibel, M; Czechowski, M; Marth, C; Hoffmann, G
    Nitric oxide-dependent apoptosis in ovarian carcinoma cell lines
    GYNECOLOGIC ONCOLOGY
    
    J. Rieder et al., "Nitric oxide-dependent apoptosis in ovarian carcinoma cell lines", GYNECOL ONC, 82(1), 2001, pp. 172-176
94. Tseng, CJ; Jain, S; Hou, HC; Liu, WW; Pao, CC; Lin, CT; Horng, SG; Soong, YK; Hsueh, S
    Applications of the telomerase assay in peritoneal washing fluids
    GYNECOLOGIC ONCOLOGY
    
    C.J. Tseng et al., "Applications of the telomerase assay in peritoneal washing fluids", GYNECOL ONC, 81(3), 2001, pp. 420-423
95. Cormio, G; Di Vagno, G; Di Fazio, F; Loverro, G; Selvaggi, L
    Intramedullary spinal cord metastasis from ovarian carcinoma
    GYNECOLOGIC ONCOLOGY
    
    G. Cormio et al., "Intramedullary spinal cord metastasis from ovarian carcinoma", GYNECOL ONC, 81(3), 2001, pp. 506-508
96. Davidson, B; Nesland, JM; Goldberg, I; Kopolovic, J; Gotlieb, WH; Byrne, M; Ben-Baruch, G; Berner, A; Reich, R
    Caveolin-1 expression in advanced-stage ovarian carcinoma - A clinicopathologic study
    GYNECOLOGIC ONCOLOGY
    
    B. Davidson et al., "Caveolin-1 expression in advanced-stage ovarian carcinoma - A clinicopathologic study", GYNECOL ONC, 81(2), 2001, pp. 166-171
97. Bristow, RE; Duska, LR; Montz, FJ
    The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma
    GYNECOLOGIC ONCOLOGY
    
    R.E. Bristow et al., "The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma", GYNECOL ONC, 81(1), 2001, pp. 92-99
98. Ng, JS; Han, AC; Edelson, MI; Rosenblum, NG
    Uterine papillary serous carcinoma presenting as distant lymph node metastasis
    GYNECOLOGIC ONCOLOGY
    
    J.S. Ng et al., "Uterine papillary serous carcinoma presenting as distant lymph node metastasis", GYNECOL ONC, 80(3), 2001, pp. 417-420
99. Hirai, M; Nakagawara, A; Oosaki, T; Hayashi, Y; Hirono, M; Yoshihara, T
    Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma
    GYNECOLOGIC ONCOLOGY
    
    M. Hirai et al., "Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma", GYNECOL ONC, 80(2), 2001, pp. 181-188
100. Toy, EP; Chambers, JT; Kacinski, BM; Flick, MB; Chambers, SK
     The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma
     GYNECOLOGIC ONCOLOGY
     
     E.P. Toy et al., "The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma", GYNECOL ONC, 80(2), 2001, pp. 194-200